跳到主要內容

Sherman Mark Andrew 的 Form 4 申報

Dolby Laboratories, Inc.(DLB),2021/12/16 申報

申報編號
0001209191-21-070104
申報時間
2021/12/16 21:25 ET
交易日
2020/12/16-2021/12/15
申報延遲
365 天遲報
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 5 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $16.1 萬。交易後 365 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Sherman Mark AndrewCIK 0001256708高階主管(EVP, GEN. COUN. & SECRTY)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/12/15Class A Common StockF扣股繳稅處分−3,506$90.55−$317,468.346,956直接
2021/12/15Class A Common StockA公司授予取得+14,757$0.00$061,713直接
2020/12/16Class A Common StockF扣股繳稅處分−1,637$91.80−$150,276.660,076直接
2020/12/16Class A Common StockS賣出處分−1,432$90.97F7−$130,263.1758,644直接
2020/12/16Class A Common StockS賣出處分−332$91.90F8−$30,511.658,312直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2021/12/15Class A Common StockA公司授予取得+7,378$0.00$07,378直接
2021/12/15Class A Common StockA公司授予取得+30,545$0.00$030,545直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F7

The shares were sold in multiple transactions at prices ranging from $90.65 to $91.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F8

The shares were sold in multiple transactions at prices ranging from $91.81 to $92.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

備註

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)